Consider enrolling in the EMMPACT study.

This study is researching how effective an investigational study drug is at helping people with confirmed or suspected NASH and fibrosis. Other study requirements apply.

Study participants receive at no cost:

• Possible access to the study drug
• Some participants will receive placebo, which has no active ingredients
• Study support and monitoring by a healthcare team
• Education about NASH and fibrosis
• The opportunity to help advance NASH research

For more information, or to learn if you may qualify to participate in this study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit:  https://www.metabolic-institute.com/nash-clinical-trial

Living with Fatty Liver Disease (NASH)?
Join the search for an effective treatment therapy
Clinical Study Enrolling Now

For adults diagnosed with (or suspected of having) nonalcoholic fatty liver disease, this clinical research study may be of interest to you.

We are looking for adults ages 18 -75 years who have been diagnosed with nonalcoholic fatty liver disease (NASH).

The NASH-FXR clinical research study will evaluate the safety and efficacy of an investigational drug for nonalcoholic liver disease (NASH).

For more information, or to learn if you may qualify to participate in this study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit:  https://www.metabolic-institute.com/nash-fxr-study/